Related Experiment Video
Updated: Jun 15, 2025

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
A case of Conradi-Hünermann-Happle syndrome treated with topical simvastatin-cholesterol ointment
Jean Zevallos1, Stephanie Susano1
1Dermatology Service, Department of Medicine, Hospital Maria Auxiliadora, Lima, Peru.
Insights
Conradi-Hünermann-Happle syndrome, a rare genetic skin disorder affecting cholesterol metabolism, presents unique cutaneous findings. This case report explores treatment with a novel simvastatin-cholesterol ointment.
Area of Science:
- Dermatology
- Genetics
- Metabolic Disorders
Background:
- Conradi-Hünermann-Happle syndrome (CHHS) is a rare genodermatosis.
- It is caused by pathogenic variants in the emopamil binding protein (EBP) gene.
- CHHS affects cholesterol metabolism and presents with multi-systemic alterations.
Observation:
- Patients exhibit characteristic cutaneous findings, including hyperkeratotic lesions along Blaschko lines.
- These lesions can lead to scarring alopecia and atrophic patches.
- Skeletal and ophthalmological abnormalities are also associated with the syndrome.
Findings:
- This case report details a patient diagnosed with CHHS.
- The patient was treated with a topical simvastatin-cholesterol ointment.
- Treatment outcomes and clinical response were observed.
Implications:
- This case may offer insights into novel therapeutic strategies for CHHS.
- Targeting cholesterol metabolism topically could be a potential treatment avenue.
- Further research is warranted to evaluate the efficacy and safety of simvastatin-cholesterol ointment in CHHS patients.
Abstract:
Conradi-Hünermann-Happle syndrome is a rare genodermatosis affecting cholesterol metabolism caused by pathogenic variants in the emopamil binding protein (EBP) gene. It presents with skin, skeletal, and ophthalmological alterations. Cutaneous findings include hyperkeratotic lesions following Blaschko lines that subsequently improve leaving scarring alopecia and patches of atrophy. The purpose of this case report is to present a case of a patient treated with simvastatin-cholesterol ointment.
More Related Videos
07:29Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
Published on: November 12, 2015
06:15Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Cholinergic Antagonists: Pharmacokinetics